✦ LIBER ✦
A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
✍ Scribed by Peter Hersey; Jeffrey Sosman; Steven O'Day; Jon Richards; Agop Bedikian; Rene Gonzalez; William Sharfman; Robert Weber; Theodore Logan; Manuela Buzoianu; Luz Hammershaimb; John M. Kirkwood
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 187 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.